Pre-close Trading Update

Advanced Medical Solutions Grp PLC 11 July 2006 For Immediate release 11 July 2006 Advanced Medical Solutions Group plc ('AMS' or 'the Company') Pre-close trading update Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, is pleased to update investors on trading as it enters the close period for the half year ending 30 June 2006. Dr. Geoffrey Vernon, Chairman of AMS, stated: 'The Company continues to trade in line with our expectations and make steady progress in delivering a number of major organic growth opportunities. The recent European approval of its ionic silver alginate woundcare range allows further expansion into the dynamic silver market. These products, which have broad anti-microbial properties that help to prevent infections such as MRSA, are expected to be introduced during the second half of 2006 through key branded partners. The Company continues to make progress with its direct NHS business. Fourteen NHS Hospital and Primary Care Trusts across England and Scotland have now adopted the ActivHeal(R) range of advanced woundcare products allowing them to achieve substantial cost savings at a time of severe funding pressures without compromising patient care. Many more centres are currently evaluating the product offering. A number of NHS Ambulance Trusts have also now adopted LiquiBand(TM) tissue adhesive and are using the product to close trauma wounds at the point of injury. Approval of the Company's LiquiBand(TM) tissue adhesives range continues on track in the US and Far East for 2007, areas which we believe will be of significant value creation in the future. - ENDS - For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508 Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development and manufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move from product design and development through to production and delivery ready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology in cyanoacrylate based tissue adhesives that offer benefits over sutures and staples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key global markets and strategic partners. This information is provided by RNS The company news service from the London Stock Exchange
UK 100